SpanishSpanish    SMSSend SMS
Yashica Pharmaceuticals
Yashica Pharmaceuticals
Yashica Pharmaceuticals

Yashica Pharmaceuticals

Yashica

Yashica PharmaceuticalsYashica Pharmaceuticals

Home » Finished Formulation » Haloperidol Injection

Haloperidol Injection

«  Back | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Next  »

NAME OF PRODUCT : YASHIPERIDOL INJECTION 5 MG/ML (HALOPERIDOL INJECTION BP 5MG/ML)
TEST SPECIFICATION AS PER USP
Description A clear colourless solution in amber glass ampoules
Identification Should comply as pr BP
Volume Variation NLT 1.0 mL
Particulate Matter Sample should be free from particles
Sterility Should comply as per BP
Related Substances Should comply as per BP
Assay - Each mL contains:
Halperidol BP – 5 mg
95.0% to 105.0%





Yes! I am Interested

Hydrocortisone Sodium Succinate Injection

NAME OF PRODUCT : YASHICORT 500 (HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION BP)
TEST SPECIFICATION AS PER USP
Description A white powder along with water for injection.
Assay - Each mL contains:
Hydrocortisone Sodium Succinate 500 mg
90.0% to 110.0%

NAME OF PRODUCT : YASHICORT 250 (HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION BP)
TEST SPECIFICATION AS PER USP
Description A white powder along with water for injection.
Assay - Each mL contains:
Hydrocortisone Sodium Succinate 250 mg
90.0% to 110.0%

NAME OF PRODUCT : YASHICORT 750 (HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION BP)
TEST SPECIFICATION AS PER USP
Description A white powder along with water for injection.
Assay - Each mL contains:
Hydrocortisone Sodium Succinate 750 mg
90.0% to 110.0%

Yes! I am Interested

Hyoscine Butylromide Injection

NAME OF PRODUCT : YASHISPAN (HYOSCINE BUTYLBROMIDE INJECTION BP 20 MG/ML)
TEST SPECIFICATION AS PER USP
Description A clear colourless solution in amber glass ampoules
Identification Should comply as pr BP
Volume Variation NLT .0 mL
Particulate Matter Sample should be free from particles
Sterility Should comply as per BP
Related Substances Should comply as per BP
Assay - Each mL contains: Hyoscine Butylbromide BP – 20 mg 95.0% to 105.0%




Yes! I am Interested

Isosorbide Tablets

NAME OF PRODUCT : YASHISORBI (Isosorbide Dinitrate Sublingual Tablets USP 5 mg)
TEST SPECIFICATION AS PER USP
Description A white coloured, round shaped, biconvex uncoated sublingual tablet plain on other side.
Identification by IR Should comply as per USP
Uniformity of weight within ± 7.5% of average weight
Average Weight 100.00 mg ± 7.5%
Hardness NLT 2.0 kg/cm2
Thickness 3.00 mm ± 0.2 mm
Diameter 6.00 mm ± 0.2 mm
Friability NMT 1.0 %
Uniformity of Content 85.0% to 115.0%
Disintegration Time NMT 2 min
Dissolution NLT 80.0% (Q) of LA
Related Substances Should comply as per BP
Assay of Isosorbide Dinitrate 90.0% to 110.0% of Label claim

Yes! I am Interested

Ketorolac Tablets

NAME OF PRODUCT : YASHIKETIN (Ketorolac Tromethamine Tablets USP 10 mg)
TEST SPECIFICATION AS PER USP
Description A yellow coloured, round shaped, biconvex film coated tablet plain on both side.
Identification by IR Should comply as per USP
Uniformity of weight within ± 7.5% of average weight
Average Weight 185.85 mg ± 5%
Friability NMT 1.0 %
Uniformity of Content 85.0% to 115.0%
Disintegration Time NMT 30 min
Dissolution NLT 75.0% (Q) of LA
Assay 90.0% to 110.0% of Label claim

Yes! I am Interested

Lignocaine & Adrenaline Injection

NAME OF PRODUCT : LIGNOCAINE AND ADRENALINE INJECTION 1.8 ML
TEST SPECIFICATION AS PER BP
Description A clear colourless solution
Identification Should comply as pr BP
Volume Variation NLT 1.8 mL
Particulate Matter Sample should be free from particles
Sterility Should comply as per BP








Yes! I am Interested

Lignocaine Injection

NAME OF PRODUCT : LIGNOCAINE INJECTION 2%W/V
TEST SPECIFICATION
Description A clear colourless solution
Identification Should comply as pr BP
Volume Variation NLT 1.8 mL
Particulate Matter Sample should be free from particles
Sterility Should comply as per BP









Yes! I am Interested

Mebendazole Tablets

NAME OF PRODUCT : YASHIMEB (Mebendazole Tablets USP 100 mg)
TEST SPECIFICATION
Description A off white coloured, round shaped, biconvex uncoated tablet plain on both side.
Identification by IR Should comply as per USP
Uniformity of weight within ± 5% of average weight
Average Weight 420.00 mg ± 7.5%
Hardness NLT 3.0 kg/cm2
Thickness 4.60 mm ± 0.2 mm
Diameter 11.11 mm ± 0.2 mm
Friability NMT 1.0 %
Disintegration Time NMT 15 min
Dissolution NLT 75.0% (Q) of LA
Related Substances Should comply as per BP
Assay Mebendazole USP 90.0% to 110.0% of Label claim

Yes! I am Interested

«  Back | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Next  »

Our Product Range :     Active Pharmaceuticals Ingredients |Drug Intermediates | Finished Formulation

Home|About Us|Our Product Range|Media Gallery|Contact Us|Enquiry

Member INDIAMART© Yashica Pharmaceuticals Private Limited. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited

Looking for Product Name ?

x

Send SMS Enquiry

*Please Enter Requirment

*Please Enter valid Mobile Number

*Please Enter Proper Name